In vitro model for investigating aerosol dispersion in a simulated COVID-19 patient during high-flow nasal cannula treatment
The use of high-flow nasal cannula in the treatment of COVID-19 infected patients has proven to be a valuable treatment option to improve oxygenation. Early in the pandemic, there were concerns for the degree of risk of disease transmission to health care workers utilizing these treatments that are...
Main Authors: | James A. McGrath, Andrew O’Sullivan, Mary Joyce, Miriam A. Byrne, Jie Li, James B. Fink, Ronan MacLoughlin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1002659/full |
Similar Items
-
The Impact of Head Model Choice on the In Vitro Evaluation of Aerosol Drug Delivery
by: Lauren Gallagher, et al.
Published: (2021-12-01) -
In-Line Aerosol Therapy via Nasal Cannula during Adult and Paediatric Normal, Obstructive, and Restrictive Breathing
by: Marc Mac Giolla Eain, et al.
Published: (2023-11-01) -
Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation
by: Mary Joyce, et al.
Published: (2021-02-01) -
In Vitro Determination of the Main Effects in the Design of High-Flow Nasal Therapy Systems with Respect to Aerosol Performance
by: Gavin Bennett, et al.
Published: (2018-06-01) -
An in vitro study of the effects of respiratory circuit setup and parameters on aerosol delivery during mechanical ventilation
by: Leanne Reilly, et al.
Published: (2024-01-01)